12.03.17 Compliance

SEC investigations in the Pharmaceutical industry in China

Leaf has represented a pharmaceutical company in an investigation made by the US Department of Justice and the Securities and Exchange Commission on distribution practices in China. Negotiation with Chinese authorities regarding the same facts.

On this subject.

23.02.20

Cybersecurity for European Luxury Group and Mass Retail

23.02.20

Retail – Loi Sapin 2 / anti-corruption practice by Leaf

23.02.20

Cybersecurity on Smart Advertising in highly regulated public spaces

23.02.20

Cybersecurity for E-commerce Operators

23.02.20

Cybersecurity on the management digital systems of a leading exhibition organizer

23.02.20

Executive Liability programs

23.02.20

Corporate Social Credit in Industry and Energy

25.01.20

Cybersecurity Law Audit Related to Carsharing Software

25.01.20

Data and Cybersecurity due diligence related to M&A operations

25.01.19

Risk Analysis in Big Data Business